Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Address Pharmacy Recommendations for Psychotropic Medication

Pendleton, Oregon Survey Completed on 08-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that pharmacy recommendations regarding medication management were addressed by the physician for one resident reviewed for unnecessary medications. Specifically, a resident with Parkinson's disease and difficulty walking was prescribed trazodone, an antidepressant, without a documented diagnosis or clinical rationale for its use. Pharmacy reviews in both June and July identified the lack of an appropriate diagnosis for the new psychotropic medication and recommended that a diagnosis be provided. Despite these recommendations, the resident continued to receive trazodone for 29 days without the required documentation. Interviews with the facility's pharmacist confirmed that monthly reviews were conducted to ensure appropriate clinical diagnoses for all medications, including psychotropics, and acknowledged the absence of a diagnosis for trazodone. The Director of Nursing Services also recognized a delay in documenting clinical rationales for medications and confirmed that the pharmacy's recommendation was not followed up on in a timely manner.

An unhandled error has occurred. Reload 🗙